Back in March, I discussed the NHS’s initiative to evaluate AI’s ability to speed up breast cancer diagnosis.
Now, another major development has taken place in the medical sector: MIT scientists have used artificial intelligence to develop potentially revolutionary antibiotics that could fight drug-resistant bacteria, and treat MRSA infections and gonorrhoea.
Read the full article in DPA's September 2025 issue